Overview | Agenda | Faculty Materials | Administration | Contact Us
Privacy Policy | Past Audioconferences | Audioconference Home






National Pharma Audioconference: An Update on FCPA Enforcement in the Life Sciences Industry

Monday, December 13, 2010

1:00 pm - 2:30 pm (Eastern)
12:00 pm - 1:30 pm (Central)
11:00 am - 12:30 pm (Mountain)
10:00 am - 11:30 am (Pacific)


AUDIOCONFERENCE FACULTY

Ted Acosta, Esq.
Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY and Paris, France

John S. Darden, Esq.
Partner, Patton Boggs LLP, Former Assistant Chief, Criminal Division, US Department of Justice, Washington, DC

Tracy L. Price, Esq.
Assistant Director, Foreign Corrupt Practices Act Unit, US Securities & Exchange Commission, Division of Enforcement, Washington, DC



Matthew Hay
Editor, Rx Compliance Report, Washington, DC (Moderator)


AUDIOCONFERENCE AGENDA
The Audioconference agenda is set forth in Eastern Daylight Time below:
1:00 pm Welcome and Introductions

Matthew Hay
Publisher, Rx Compliance Report (Moderator)
1:05 pm Update on DOJ FCPA Investigations into the Life Sciences Industry

John S. Darden, Esq.
Partner, Patton Boggs LLP, Former Assistant Chief, Criminal Division, US Department of Justice, Washington, DC
1:25 pm Update on SEC Enforcement of the FCPA

Tracy L. Price, Esq.
Assistant Director, Foreign Corrupt Practices Act Unit, US Securities & Exchange Commission, Division of Enforcement, Washington, DC
1:50 pm Update on Global Anti-Bribery and Anti-Corruption Initiatives

Ted Acosta, Esq.
Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY and Paris, France
2:15 pm Questions & Answers
2:30 pm Audioconference Adjournment

SAVE THE DATE
THIRD ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES
A Hybrid Conference, Internet Event and Training Tool
The Leading Forum on Disclosure, Transparency and Aggregate Spend for Drug, Device and Biotech Companies
Media Partner: Harvard Health Policy Review, Health Affairs, and RxCompliance Report
March 9 - 11, 2011
Wardman Park Hotel
Washington, DC
www.DisclosureSummit.com
FIFTH INTERNATIONAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
Sponsored by Pharmaceutical Compliance Forum
Media Partner: Harvard Health Policy Review
May 3 - 5, 2011
Istanbul, Turkey
www.InternationalPharmaCongress.com
FIRST ASIAN INTERNATIONAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
Media Partner: Harvard Health Policy Review
September 2011
Singapore
www.AsianPharmaCongress.com
TWELFTH ANNUAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
Sponsored by Pharmaceutical Compliance Forum
Media Partner: Harvard Health Policy Review, Health Affairs, and RxCompliance Report
November 2011
Washington, DC
www.PharmaCongress.com


SPONSORED BY:











We subscribe to the HONcode principles of the HON Foundation. Click to verify.



Overview | Agenda | Faculty Materials | Administration | Contact Us
Privacy Policy | Past Audioconferences | Audioconference Home




© Health Care Conference Administrators
Contact Webmaster